# Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects

> **NCT04324359** · PHASE2 · COMPLETED · sponsor: **Surface Ophthalmics, Inc.** · enrollment: 91 (actual)

## Conditions studied

- Post-surgical Ocular Inflammation
- Post-surgical Ocular Pain

## Interventions

- **DRUG:** SURF-201
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04324359
- **Lead sponsor:** Surface Ophthalmics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-03
- **Primary completion:** 2020-11-03
- **Final completion:** 2020-11-20
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04324359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04324359, "Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04324359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*